newsfilter
← Latest News
Business Wire·

Sesen Bio and Carisma Therapeutics Announce Merger Agreement

Transaction to create a well-funded, clinical-stage biotechnology company advancing engineered macrophages for the treatment of cancer and other serious disorders Combined company expected to have approximately $180 million of cash, cash equivalents